Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
National Journal of Medical Research ; 12(3):97-99, 2021.
Article in English | GIM | ID: covidwho-1717278

ABSTRACT

"Introduction: The novel coronavirus, SARS-CoV-2 presented with a wide array of clinical, inflammatory and radiological manifestations. Currently, a very few data is available about the relationship in between pattern of fever and biochemical parameters in patients affected by COVID-19. Our objective is to find out the clinical and inflammatory status of COVID-19 patients and whether there is a relationship in between pattern of fever and biochemical parameters of severe acute respiratory syndrome coronavirus disease 2. Methodology: A retrospective study conducted on 60 COVID-19 positive patients, who were clinically/radiologically evaluated and screened for inflammatory markers. Result: 39 men and 21 women had Fever and elevated inflammatory markers like CRP, D-dimer, ferritin, ESR. Altered neutrophil lymphocyte ratio was also found. Patients with moderate and severe grade fever had more significant rise in CRP (60%), D-dimer (50%).patients with mild and moderate fever had more rise of ferritin (65%). ESR and NLR were not significantly increased. Patients with intermittent fever had high rise in CRP (80%), D-dimer (75%), and ferritin (72%). Again, ESR was not significantly raised. NLR was moderately raised in patients with continuous fever (66%). Sub acute and chronic rise of temperature shows more significant rise in CRP (60%), D-dimer (82%), ferritin (80%), NLR and ESR.

2.
National Journal of Medical Research ; 11(4):121-124, 2021.
Article in English | GIM | ID: covidwho-1717277

ABSTRACT

Introduction: Since the end of 2019, the world is witnessing the emergence of the coronavirus disease 2019 (COVID-19) outbreak and pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This disease presented with a wide array of clinical, inflammatory and possible autoimmune manifestations. Currently, a very few data is available about the involvement of autoimmunity in patients affected by coronavirus disease 2019 (COVID-19). Aim: To find out the clinical and inflammatory status of COVID-19 patients and whether this disease (SARS-CoV-2) stimulates autoantibody production and contributes to autoimmunity activation. Methodology: A hospital based retrospective study conducted on 60 COVID-19 patients. All patients were clinically and radiologically evaluated and screened for common inflammatory markers and auto antibodies. Result: Patients included were 39 men (65%) and 21 women (35%). 33 patients were mild cases, 15 were moderate and 12 were severe cases with a mean age of 44.27. Fever and shortness of breath were the dominant symptoms;most patients had at least one coexisting disorder on admission;the most common characteristic on chest CT was groundglass opacity;the most common findings on laboratory measurements of inflammatory markers were elevated levels of CRP, LDH, ferritin and altered neutrophil lymphocyte ratio;and prevalence of autoantibodies, anti SSA/Ro antibody, anti SSB/La antibody, and antinuclear antibody was 20%, 10%, and 15%, respectively and Anti-TPO antibody was positive in 33.3% patients.

SELECTION OF CITATIONS
SEARCH DETAIL